Previous 10 | Next 10 |
ANI Pharmaceuticals, Inc. (ANIP) Q1 2021 Earnings Conference Call May 07, 2021 08:30 AM ET Company Participants Lisa Wilson - In-Site Communications, Investor Relations Nikhil Lalwani - President & Chief Executive Officer Stephen Carey - Chief Financial Officer Conference Call Participant...
Image source: The Motley Fool. ANI Pharmaceuticals Inc (NASDAQ: ANIP) Q1 2021 Earnings Call May 7, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript
ANI Pharmaceuticals (ANIP): Q1 Non-GAAP EPS of $1.04 beats by $0.33; GAAP EPS of $0.01 beats by $0.29.Revenue of $54.52M (+9.5% Y/Y) beats by $7.72M.Press Release For further details see: ANI Pharmaceuticals EPS beats by $0.33, beats on revenue
-- First quarter 2021 net revenues of $54.5 million; net income of $0.1 million and diluted earnings per share of $0.01 -- -- First quarter adjusted non-GAAP EBITDA of $18.9 million and adjusted non-GAAP diluted earnings per share of $1.04 -- -- Cortrophin ® G...
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2021 financial results on Friday, May 7, 2021. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, S...
ANI Pharmaceuticals (ANIP) has acquired the new drug applications (NDAs) for Oxistat Lotion, Veregen Ointment, and Pandel Cream and the abbreviated new drug application for ApexiCon E Cream from Sandoz Inc.Pandel Cream will be transitioned later upon receiving the requisite app...
-- Accretive transaction in line with growth strategy laid out for Branded Products business -- ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ:ANIP) today announced that it has acquired the new drug applications (“NDAs”) for OXISTAT ® Lotion, VERE...
ANI Pharmaceuticals, Inc. (ANIP) Q4 2020 Earnings Conference Call March 9, 2021 08:30 ET Company Participants Lisa Wilson - In-Site Communications, Investor Relations Nikhil Lalwani - President & Chief Executive Officer Stephen Carey - Chief Financial Officer Conference Call Participants ...
ANI Pharmaceuticals ([[ANIP]] -1.4%) has agreed to acquire privately-held Novitium Pharma for a total consideration of $163.5M in cash and equity.The transaction is expected to close in H2 2021, subject to regulatory approvals and approval by ANI shareholders.The purchase price incl...
Image source: The Motley Fool. ANI Pharmaceuticals Inc (NASDAQ: ANIP) Q4 2020 Earnings Call Mar 9, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: ANI Pharmaceuticals Inc (ANIP) Q4 2020 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
ANI Pharmaceuticals Inc. Company Name:
ANIP Stock Symbol:
NASDAQ Market:
ANI Pharmaceuticals Inc. Website:
PRINCETON, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2024 financial results on Tuesday, August 6, 2024, prior to the market open. Nikh...
PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched L-Glutamine Oral Po...
2024-07-09 17:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...